Author(s): Susi Ari Kristina, Tri Murti Andayani, Galih Putri Wulandari
DOI: 10.5958/0974-360X.2020.00089.X
Views:
27
(pdf),
2224
(html)
Access:
Open Access
Cite: Susi Ari Kristina, Tri Murti Andayani, Galih Putri Wulandari. A Systematic Review of the Direct and Indirect Costs among Tuberculosis Patients. Research J. Pharm. and Tech. 2020; 13(1): 456-460. doi: 10.5958/0974-360X.2020.00089.X
Read More
|
Author(s): Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati
DOI: 10.5958/0974-360X.2020.00086.4
Views:
110
(pdf),
1831
(html)
Access:
Open Access
Cite: Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati. Health-Related Quality of Life in Non-Small Cell Lung Cancer (NSCLC) Patients with Mutation of Epidermal Growth Factor Receptor (EGFR) in Indonesia. Research J. Pharm. and Tech. 2020; 13(1):443-447. doi: 10.5958/0974-360X.2020.00086.4
Read More
|
Author(s): Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati
DOI: 10.52711/0974-360X.2022.00267
Views:
11
(pdf),
1486
(html)
Access:
Open Access
Cite: Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati. Cost-Effectiveness Analysis of Afatinib versus Gefitinib in Non-small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) Mutation in Indonesia: Observational studies with Retrospectives. Research Journal of Pharmacy and Technology. 2022; 15(4):1598-2. doi: 10.52711/0974-360X.2022.00267
Read More
|
Author(s): Endang Sunariyanti, Tri Murti Andayani, Dwi Endarti, Diah Ayu Puspandari
DOI: 10.52711/0974-360X.2023.00293
Views:
27
(pdf),
1267
(html)
Access:
Open Access
Cite: Endang Sunariyanti, Tri Murti Andayani, Dwi Endarti, Diah Ayu Puspandari. Cost Analysis of Therapy of Chronic Kidney Disease Inpatient In Indonesia. Research Journal of Pharmacy and Technology 2023; 16(4):1781-9. doi: 10.52711/0974-360X.2023.00293
Read More
|